Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07023276 · ClinicalTrials.gov registry record · NA
Agility and Performance Among High School Basketball Players Following a Coach-Led Neuromuscular Training Program
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT07023276: Completed NA study, sponsored by Hospital for Special Surgery, New York.
NCT07023276 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07023276, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The purpose of this study is to examine changes in agility and athletic performance of high school basketball players following a coach-led neuromuscular training program. Outcomes were measured at pre- and post-season data collection sessions. Additionally, player attendance and warm-up adherence was self recorded by coaches.
Primary Outcome
The lane agility was performed according to previously published methods (Stojanović et al. 2019). The LAT was set up around the basketball court using small cones. Players started at the bottom left corner of the key underneath the basket and sprinted to the cone on the left corner of the free throw line. Players side shuffled to the right, across the free-throw line to the next cone (on the right corner of the free throw line) and then backpedaled towards the third cone at the baseline. Next,
Interventions
- OTHER Neuromuscular Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2023-11-27 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
What the finished NCT07023276 record still lists
NCT07023276 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Neuromuscular Training is the first listed.
NCT07023276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07023276 about?
NCT07023276 is a clinical study titled "Agility and Performance Among High School Basketball Players Following a Coach-Led Neuromuscular Training Program". The purpose of this study is to examine changes in agility and athletic performance of high school basketball players following a coach-led neuromuscular training program. Outcomes were measured at pre- and post-season data collection sessions. Additionally, player attendance and warm-up adherence w...
What is the current status of trial NCT07023276?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2023-11-27. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT07023276?
The interventions under investigation include: Neuromuscular Training (OTHER).
Who is sponsoring clinical trial NCT07023276?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07023276's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI